Aier Eye Hospital Group Co (300015) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
24 Apr, 2026Executive summary
Revenue for Q1 2026 reached ¥6.40 billion, up 6.15% year-over-year, with net profit attributable to shareholders rising 12.46% to ¥1.18 billion.
Operating cash flow decreased 6.18% year-over-year to ¥1.71 billion.
Total assets at quarter-end were ¥36.58 billion, slightly down 0.26% from year-end 2025.
Financial highlights
Revenue increased 6.15% year-over-year, driven by stable growth across hospitals.
Net profit attributable to shareholders rose 12.46% year-over-year; EPS was ¥0.1274, up 12.15%.
Gross margin improved as revenue growth outpaced cost increases.
Non-recurring gains included government subsidies and asset disposals totaling ¥4.78 million.
Outlook and guidance
Revenue and profit growth attributed to expanded operating scale and stable hospital performance.
Management expects continued growth as hospital network expands.
Latest events from Aier Eye Hospital Group Co
- Revenue up 3.81% but net profit down 33.83% amid digital and global expansion.300015
H1 2026 - Revenue up 3.83% in Q3, but net profit down 24.12% year-over-year.300015
Q3 2025 - Revenue up 9.12% to ¥11.51B, net profit stable, digital and AI strategy advanced.300015
H1 2025 - Q3 profit dipped, but nine-month net profit and assets grew on hospital acquisitions.300015
Q3 2024 - Net profit surged 19.71% to ¥2.05B on steady revenue growth and global expansion.300015
H1 2024 - Q1 2025 revenue and net profit surged over 15% year-over-year, led by hospital network growth.300015
Q1 2025 - 2024 revenue up 3.02% to ¥20.98B, net profit up 5.87%, dividend payout 41.82%.300015
H2 2024